Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 388


Listeria monocytogenes Associated with Pasteurized Chocolate Milk, Ontario, Canada.

Hanson H, Whitfield Y, Lee C, Badiani T, Minielly C, Fenik J, Makrostergios T, Kopko C, Majury A, Hillyer E, Fortuna L, Maki A, Murphy A, Lombos M, Zittermann S, Yu Y, Hill K, Kong A, Sharma D, Warshawsky B.

Emerg Infect Dis. 2019 Mar;25(3):581-584. doi: 10.3201/eid2503.180742.


Tissue distribution of tetrabromobisphenol A and cadmium in mixture inhalation exposure.

Chen J, Kang D, Yan Z, Shen Q, Lou Y, Li Y, Kong A, Pan B, Huang C.

Toxicol Ind Health. 2019 Feb;35(2):165-176. doi: 10.1177/0748233718820983.


Screening of endogenous strong promoters for enhanced production of medium-chain-length polyhydroxyalkanoates in Pseudomonas mendocina NK-01.

Zhao F, Liu X, Kong A, Zhao Y, Fan X, Ma T, Gao W, Wang S, Yang C.

Sci Rep. 2019 Feb 12;9(1):1798. doi: 10.1038/s41598-019-39321-z.


Pre-diagnostic carbohydrate intake and treatment failure after radical prostatectomy for early-stage prostate cancer.

Kim K, Kong A, Flanigan RC, Quek ML, Hollowell CMP, Vidal PP, Branch J, Dean LA, Macias V, Kajadacsy-Balla AA, Fitzgibbon ML, Cintron D, Liu L, Freeman VL.

Cancer Causes Control. 2019 Feb 7. doi: 10.1007/s10552-019-1134-4. [Epub ahead of print]


Hsp74/14-3-3σ Complex Mediates Centrosome Amplification by High Glucose, Insulin and Palmitic Acid.

Lu YC, Wang P, Wu QG, Zhang RK, Kong A, Li YF, Lee SC.

Proteomics. 2019 Jan 28:e1800197. doi: 10.1002/pmic.201800197. [Epub ahead of print]


Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.

Mumin NH, Drobnitzky N, Patel A, Lourenco LM, Cahill FF, Jiang Y, Kong A, Ryan AJ.

BMC Cancer. 2019 Jan 24;19(1):102. doi: 10.1186/s12885-019-5295-z.


A Pilot Study of the Effect of an Educational Web Application on Asthma Control and Medication Adherence.

Weinstein AG, Singh A, Laurenceau JP, Skoner DP, Maiolo J, Sharara R, Ma K, Cheema T, Butler E, Kong A, Thakkar P, Gentile DA.

J Allergy Clin Immunol Pract. 2019 Jan 11. pii: S2213-2198(19)30049-2. doi: 10.1016/j.jaip.2018.12.024. [Epub ahead of print]


Bio-inspired chitosan-heme-vitamin B12-derived Fe-Co bimetallic-doped mesoporous carbons for efficiently electro-activating oxygen.

Ma Z, Xu L, Liu L, Wang L, Zhang X, Kong A.

Dalton Trans. 2019 Feb 12;48(7):2338-2344. doi: 10.1039/c8dt04279a.


Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck.

Golusinski P, Di Maio P, Pehlivan B, Colley S, Nankivell P, Kong A, Hartley A, Mehanna H.

Oral Oncol. 2019 Jan;88:145-152. doi: 10.1016/j.oraloncology.2018.11.020. Epub 2018 Nov 30. Review.


DeltaMass: Automated Detection and Visualization of Mass Shifts in Proteomic Open-Search Results.

Avtonomov DM, Kong A, Nesvizhskii AI.

J Proteome Res. 2019 Feb 1;18(2):715-720. doi: 10.1021/acs.jproteome.8b00728. Epub 2018 Dec 17.


Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group.

Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15.


Multiple transmissions of de novo mutations in families.

Jónsson H, Sulem P, Arnadottir GA, Pálsson G, Eggertsson HP, Kristmundsdottir S, Zink F, Kehr B, Hjorleifsson KE, Jensson BÖ, Jonsdottir I, Marelsson SE, Gudjonsson SA, Gylfason A, Jonasdottir A, Jonasdottir A, Stacey SN, Magnusson OT, Thorsteinsdottir U, Masson G, Kong A, Halldorsson BV, Helgason A, Gudbjartsson DF, Stefansson K.

Nat Genet. 2018 Dec;50(12):1674-1680. doi: 10.1038/s41588-018-0259-9. Epub 2018 Nov 5.


Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.

Galot R, Le Tourneau C, Guigay J, Licitra L, Tinhofer I, Kong A, Caballero C, Fortpied C, Bogaerts J, Govaerts AS, Staelens D, Raveloarivahy T, Rodegher L, Laes JF, Saada-Bouzid E, Machiels JP.

Ann Oncol. 2018 Dec 1;29(12):2313-2327. doi: 10.1093/annonc/mdy452.


Author Correction: The rate of meiotic gene conversion varies by sex and age.

Halldorsson BV, Hardarson MT, Kehr B, Styrkarsdottir U, Gylfason A, Thorleifsson G, Zink F, Jonasdottir A, Jonasdottir A, Sulem P, Masson G, Thorsteinsdottir U, Helgason A, Kong A, Gudbjartsson DF, Stefansson K.

Nat Genet. 2018 Nov;50(11):1616. doi: 10.1038/s41588-018-0228-3.


The association of socioeconomic status with receipt of neoadjuvant chemotherapy.

Neuner JM, Kong A, Blaes A, Riley D, Chrischilles E, Smallwood A, Lizarraga I, Schroeder M.

Breast Cancer Res Treat. 2018 Sep 19. doi: 10.1007/s10549-018-4954-0. [Epub ahead of print]


Electroactive Cu-P-Coupled Moieties Doped in Hierarchically Porous Carbon as Efficient Catalysts for the Oxygen-Reduction Reaction.

Ni Y, Qiao Y, Kong F, Li R, Zhang C, Kong A, Shan Y.

Chem Asian J. 2018 Nov 2;13(21):3314-3320. doi: 10.1002/asia.201801091. Epub 2018 Oct 17.


The Expanding Role of Radiosurgery for Brain Metastases.

O'Beirn M, Benghiat H, Meade S, Heyes G, Sawlani V, Kong A, Hartley A, Sanghera P.

Medicines (Basel). 2018 Aug 14;5(3). pii: E90. doi: 10.3390/medicines5030090. Review.


Relatedness disequilibrium regression estimates heritability without environmental bias.

Young AI, Frigge ML, Gudbjartsson DF, Thorleifsson G, Bjornsdottir G, Sulem P, Masson G, Thorsteinsdottir U, Stefansson K, Kong A.

Nat Genet. 2018 Sep;50(9):1304-1310. doi: 10.1038/s41588-018-0178-9. Epub 2018 Aug 13.


National risk factors for blunt cardiac injury: Hemopneumothorax is the strongest predictor.

Grigorian A, Milliken J, Livingston JK, Spencer D, Gabriel V, Schubl SD, Kong A, Barrios C, Joe V, Nahmias J.

Am J Surg. 2018 Jul 25. pii: S0002-9610(18)30301-5. doi: 10.1016/j.amjsurg.2018.07.043. [Epub ahead of print]


An engineered Pseudomonas putida can simultaneously degrade organophosphates, pyrethroids and carbamates.

Gong T, Xu X, Dang Y, Kong A, Wu Y, Liang P, Wang S, Yu H, Xu P, Yang C.

Sci Total Environ. 2018 Jul 1;628-629:1258-1265. doi: 10.1016/j.scitotenv.2018.02.143. Epub 2018 Feb 20.


Supplemental Content

Loading ...
Support Center